MedPage Today on MSN2d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ART
SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
The American Journal of Managed Care1d
Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
Study examines a novel way to bring addiction care and HIV prevention to people who inject drugs
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
Infectious Disease Advisor2d
CD4 Recovery in Advanced HIV Slower With Anti-CD4 Autoantibodies at ART Initiation
The presence of anti-CD4 autoantibodies in treatment-naive patients with advanced HIV was associated with a decreased rate of CD4 reconstitution following ART initiation.
The Lancet2d
Prevention and control of HPV-related cancers in people living with HIV
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
Healio3d
Two more people potentially cured of HIV
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Healio2d
‘We have come a long way’: Empirical data support UNAIDS HIV incidence estimates
HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...
Clinical Advisor6d
Updated Guidelines on Breastfeeding in HIV-Positive Mothers
HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...